Abstract:Innate immune response provides the host with an early protection barrier against invading pathogens and helps shape the nature and quality of the subsequent adaptive immune response of the host. Ubiquitin-specific protease 18 (USP18 ) plays an important role in the host innate immune response. This role is mediated both via its enzymatic and non-enzymatic functions. First, conjugation of ISG15 to its targets is counteracted by the enzymatic activity of USP18. Second, the C terminus of USP18 can bind to the type I interferon receptor subunit (IFNAR2) and compete with JAK1 receptor binding which inhibits the activation of the receptor associated kinases JAK1 and TYK2. While USP18 deficiency prolonged phosphorylation of STATs and increased ISG expression in response to IFN, forced expression of either wild type or enzymatically inactive mutatant USP18 in the cells reduces the phosphorylation level of STATs and the downstream transcriptional events. USP18 knockout mice have a greater resistance to viral/bacterial infection in several experimental mouse models. In addition, USP18 was found to inhibit IFNsignaling but did not inhibit IFN, IFN, IL-6, or IL-12 signaling pathways. Results from our previous study demonstrated that USP18 was overexpressed in the liver biopsy specimens of HCV patients who do not respond to the combination therapy of pegylated interferon-alpha (IFN) and ribavirin (RBV). We also found that increased expression of either wild type USP18 or catalytically inactive mutant USP18 blunted the effect of both type I and type III IFNs and promoteded HCV production in the J6/JFH1 culture system. Another study suggested that HBV infection is more rapidly cleared if USP18 expression level is reduced. Most recently it has been shown that USP18 may play an important role in mediating inflammation. Inhibition of USP18 leads to upregulation of several pro-inflammatory chemokine, including CCL5, CXCL10 and IL-15, via induction of the STAT signaling pathway and increases IFN induced beta cell apoptosis. Taken together, small molecule inhibitors against USP18 might be a viable approach to potentiate the host innate immunity leading to a better control of viral infections.

Gene expression profile after knockdown of USP18 in Hepg2.2.15 cells.

The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity

The role of USP 18 in interferon signaling and inflammation

Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma

Comprehensive Analysis of Ubiquitin‐specific Protease 1 Reveals Its Importance in Hepatocellular Carcinoma

USP35 Promotes HCC Development by Stabilizing ABHD17C and Activating the PI3K/AKT Signaling Pathway.

Evaluation of Hepatitis B Viral Replication and Proteomic Analysis of HepG2.2.15 Cell Line after Knockdown of HBx

The Physical Examination of Patients With Abdominal Pain: The Long-Term Effect Of Adding Standardized Patients and Small-Group Feedback to a Lecture Presentation

USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells

USP18 Mediates Interferon Resistance of Dengue Virus Infection

Hepatitis B virus X protein represses expression of tumor suppressor PTPN18 in hepatocellular carcinoma

The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Dysregulation and oncogenic activities of ubiquitin specific peptidase 2a in the pathogenesis of hepatocellular carcinoma

USP18 protects against hepatic steatosis and insulin resistance via its DUB activity.

Abdominoplasty: Risk Factors, Complication Rates, and Safety of Combined Procedures

USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo

USP22 promotes tumorigenesis and progression by a FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma

Proteomic Analysis of Cell Lines Expressing Small Hepatitis B Surface Antigen Revealed Decreased Glucose‐regulated Protein 78 Kda Expression in Association with Higher Susceptibility to Apoptosis

mRNA sequencing and CyTOF analysis revealed ASPP2 altered the response patterns of hepatocellular carcinoma HepG2 cells to usnic acid

Comprehensive prognostic and immunological analysis of Ubiquitin Specific Peptidase 28 in pan-cancers and identification of its role in hepatocellular carcinoma cell lines